Reuters logo
BRIEF-Syros publishes foundational data supporting phase 2 clinical trial
July 21, 2017 / 12:15 PM / 2 months ago

BRIEF-Syros publishes foundational data supporting phase 2 clinical trial

July 21 (Reuters) - Syros Pharmaceuticals Inc:

* Syros publishes foundational data supporting ongoing phase 2 clinical trial of SY-1425 for genomically defined AML and MDS patients

* Says is on track to present initial data from phase 2 clinical trial this fall Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below